Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Emerging Adulthood01:27

Emerging Adulthood

723
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
723
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

376
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
376
Reversible and Irreversible Processes01:14

Reversible and Irreversible Processes

5.8K
The thermodynamic processes can be classified into reversible and irreversible processes. The processes that can be restored to their initial state are called reversible processes. It is only possible if the process is in quasi-static equilibrium, i.e., it takes place in infinitesimally small steps, and the system remains at equilibrium However, these are ideal processes and do not occur naturally. An ideal system undergoing a reversible process is always in thermodynamic equilibrium within...
5.8K
Diode: Reverse bias01:14

Diode: Reverse bias

2.0K
A diode is reverse-biased when the positive terminal of an external voltage source is connected to the n-type material and the negative terminal to the p-type material. This configuration opposes the natural direction of current flow through the diode, effectively increasing the width of the depletion region and the barrier potential. The reverse bias condition produces a minimal leakage current, primarily due to minority charge carriers. This leakage becomes significant when the reverse...
2.0K
Applications of GIS: Disaster Management and Emergency Response01:29

Applications of GIS: Disaster Management and Emergency Response

541
Geographic Information System (GIS) technology is essential for risk identification, action prioritization, and resource optimization in critical situations like flooding and earthquakes. By integrating spatial and demographic data, GIS provides a comprehensive framework for emergency response.GIS integrates data layers, like rainfall intensity, topography, elevation profiles, and river levels, to model high-risk flood zones. These layers assess areas susceptible to flooding based on their...
541

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial.

JACC. Advances·2026
Same author

Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE.

AIDS (London, England)·2026
Same author

Semaglutide improves markers of cardiovascular risk in people with HIV.

AIDS (London, England)·2026
Same author

Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.

The lancet. HIV·2026
Same author

Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.

The lancet. HIV·2026

Related Experiment Video

Updated: Feb 10, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Emerging reverse transcriptase inhibitors for HIV-1 infection.

Mohammad A Rai1, Sam Pannek1, Carl J Fichtenbaum1

  • 1a Department of Internal Medicine , University of Cincinnati Medical Center , Cincinnati , OH , USA.

Expert Opinion on Emerging Drugs
|May 9, 2018
PubMed
Summary

Newer antiretroviral therapies (ART) show promise for HIV treatment. Emerging drugs offer improved side effect profiles, better resistance management, and longer durations, potentially enhancing patient adherence and satisfaction.

Keywords:
DoravirineElsulfavirineGS-9191HIVHIV reverse transcriptase inhibitorsMK-8591NNRTINRTInon-nucleoside reverse transcriptase inhibitorsnucleoside reverse transcriptase inhibitors

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Published on: March 3, 2017

11.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Published on: March 3, 2017

11.1K

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antiretroviral therapy (ART) is crucial for managing HIV, with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) forming its core.
  • Existing NRTIs and non-nucleoside reverse transcriptase inhibitors (NNRTIs) face challenges including significant side effects and developing resistance.
  • Over 36 million people live with HIV globally, highlighting the need for effective and well-tolerated treatments.

Purpose of the Study:

  • To review resistance mechanisms and limitations of current NRTIs and NNRTIs.
  • To evaluate promising new agents in the development pipeline for HIV treatment.
  • To discuss the potential impact of novel reverse transcriptase inhibitors on ART.

Main Methods:

  • Literature review focusing on resistance mechanisms of NRTIs and NNRTIs.
  • Analysis of data on emerging HIV therapeutics, including GS-9131, MK-8591, Elsulfavirine, and Doravirine.
  • Expert opinion synthesis on the future of ART development.

Main Results:

  • Four new agents (GS-9131, MK-8591, Elsulfavirine, Doravirine) are in advanced development.
  • MK-8591 offers potential for longer-acting formulations to improve adherence.
  • Doravirine demonstrates efficacy against common mutations with fewer side effects and drug interactions.

Conclusions:

  • Newer reverse transcriptase inhibitors possess longer half-lives and improved safety profiles.
  • Emerging agents like Doravirine and Elsulfavirine show potential for enhanced efficacy and tolerability.
  • Advancements in ART development offer improved options for patients living with HIV.